Inspections of sites deemed to be mission critical for the US resumed last month. The American drug regulator’s India director Christopher Middendorf also said that the USFDA may grant approval without inspection if a drug belongs to an already approved profile and the manufacturer has a solid Good Manufacturing Practices recordUSFDA begins inspections of Indian manufacturing sites deemed mission-critical
Inspections of sites deemed to be mission critical for the US resumed last month. The American drug regulator’s India director Christopher Middendorf also said that the USFDA may grant approval without inspection if a drug belongs to an already approved profile and the manufacturer has a solid Good Manufacturing Practices record
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The bank plans to raise up to Rs 500 crore by issue of equity shares to qualified institutional buyers through qualified institutional plac...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment